STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2021 Results: February 2, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) will release its third quarter fiscal year 2021 financial results on February 2, 2021, at 6:00 am EDT. Following this, a conference call for investors and analysts will occur at 8:00 am EDT on the same day to discuss the results. Access to the call is available via toll-free and international numbers, with a conference ID required. A live webcast will also be available on Haemonetics' investor relations website, with a replay accessible from February 2 to February 10, 2021.

Loading...
Loading translation...

Positive

  • Scheduled release of Q3 FY2021 financial results indicates transparency.
  • Conference call provides a platform for direct investor engagement.

Negative

  • None.

Insights

Analyzing...

BOSTON, Jan. 5, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2021 financial results at 6:00 am EDT on Tuesday, February 2, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on February 2, 2021. 

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 7792833

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/6nszefg7

Webcast replay will be available from February 2, 2021 11:00 am to February 10, 2021 11:00 am EDT.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.  

Investor Contact:         

Media Contact:

Olga Guyette, Director-Investor Relations 

Carla Burigatto, VP-Global Communications

(781) 356-9763                    

(781) 348-7263

olga.guyette@haemonetics.com       

carla.burigatto@haemonetics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2021-results-february-2-2021-301201477.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics release its third quarter fiscal year 2021 financial results?

Haemonetics will publish its financial results on February 2, 2021, at 6:00 am EDT.

What time is the conference call for Haemonetics' Q3 FY2021 results?

The conference call will take place at 8:00 am EDT on February 2, 2021.

How can investors access the Haemonetics Q3 FY2021 earnings call?

Investors can access the call via toll-free and international numbers, and the conference ID is 7792833.

Will there be a replay of the Haemonetics earnings call?

Yes, a webcast replay will be available from February 2, 2021, at 11:00 am to February 10, 2021, at 11:00 am EDT.
Haemonetics Corp Mass

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Latest SEC Filings

HAE Stock Data

3.92B
46.23M
1.15%
115.65%
7.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BOSTON